These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16797164)

  • 1. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
    Pai MS; Yang SN; Shiah IS
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):538. PubMed ID: 23066778
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of zotepine for the treatment of schizophrenia.
    Riedel M; Musil R; Seemüller F; Spellmann I; Möller HJ; Schennach-Wolff R
    Expert Opin Drug Saf; 2010 Jul; 9(4):659-66. PubMed ID: 20486863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
    Huang WL; Chang LR
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of clinical efficacy and pharmacological action of zotepine.
    Yamawaki S
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):4-7. PubMed ID: 2883681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convulsive seizures in schizophrenic patients induced by zotepine administration.
    Hori M; Suzuki T; Sasaki M; Shiraishi H; Koizumi J
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):161-7. PubMed ID: 1353125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM; Müller-Spahn F; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectivity of zotepine in refractory psychoses: possible relationship between zotepine and non-dopamine psychosis.
    Harada T; Otsuki S; Sato M; Wake A; Fujiwara Y; Kashihara K; Fukuda K
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):47-51. PubMed ID: 2883682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Int Clin Psychopharmacol; 1992; 7(1):23-7. PubMed ID: 1352521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zotepine: a clinical review.
    Green B
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):181-6. PubMed ID: 19199377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zotepine in the treatment of acute hospitalized schizophrenic episodes.
    Kasper S; Quiner S; Barnas C; Fabisch H; Haushofer M; Sackel C; König P; Lingg A; Platz T; Rittmannsberger H; Stuppäck C; Willeit M; Zapotoczky HG
    Int Clin Psychopharmacol; 2001 May; 16(3):163-8. PubMed ID: 11354238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 19. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
    Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
    J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
    [No Abstract]   [Full Text] [Related]  

  • 20. Zotepine-induced spontaneous ejaculation.
    Wang PW; Wang SY; Huang CJ
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):571-3. PubMed ID: 19000555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.